271 related articles for article (PubMed ID: 30293702)
1. Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature.
Francolini G; Detti B; Ingrosso G; Desideri I; Becherini C; Carta G; Pezzulla D; Caramia G; Dominici L; Maragna V; Teriaca MA; Bottero M; Livi L
Crit Rev Oncol Hematol; 2018 Nov; 131():24-29. PubMed ID: 30293702
[TBL] [Abstract][Full Text] [Related]
2. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
[TBL] [Abstract][Full Text] [Related]
3. Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma.
Ponsky L; Lo SS; Zhang Y; Schluchter M; Liu Y; Patel R; Abouassaly R; Welford S; Gulani V; Haaga JR; Machtay M; Ellis RJ
Radiother Oncol; 2015 Oct; 117(1):183-7. PubMed ID: 26362723
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK
Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242
[TBL] [Abstract][Full Text] [Related]
5. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
[TBL] [Abstract][Full Text] [Related]
6. Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT).
Altoos B; Amini A; Yacoub M; Bourlon MT; Kessler EE; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Radiat Oncol; 2015 Oct; 10():218. PubMed ID: 26510665
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?
Carrasco-Esteban E; Barrionuevo-Castillo P; Domínguez-Rullán J; Gómez-Aparicio MA; Ferri-Molina M; Sáez-Bueno P; Zalabarría-Zarrabeitia Z; Scorsetti M; Arcangeli S; López-Campos F; Couñago F
Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):163-176. PubMed ID: 36443137
[TBL] [Abstract][Full Text] [Related]
8. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
Miccio JA; Oladeru OT; Jun Ma S; Johung KL
Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
[TBL] [Abstract][Full Text] [Related]
9. Radiosurgery for Treatment of Renal Cell Metastases to Spine: A Systematic Review of the Literature.
Smith BW; Joseph JR; Saadeh YS; La Marca F; Szerlip NJ; Schermerhorn TC; Spratt DE; Younge KC; Park P
World Neurosurg; 2018 Jan; 109():e502-e509. PubMed ID: 29038086
[TBL] [Abstract][Full Text] [Related]
10. A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases.
Jhaveri PM; Teh BS; Paulino AC; Blanco AI; Lo SS; Butler EB; Amato RJ
Acta Oncol; 2012 May; 51(5):584-8. PubMed ID: 22248089
[TBL] [Abstract][Full Text] [Related]
11. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
Miccio J; Johung K
Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Stinauer MA; Kavanagh BD; Schefter TE; Gonzalez R; Flaig T; Lewis K; Robinson W; Chidel M; Glode M; Raben D
Radiat Oncol; 2011 Apr; 6():34. PubMed ID: 21477295
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Rühle A; Andratschke N; Siva S; Guckenberger M
Clin Transl Radiat Oncol; 2019 Sep; 18():104-112. PubMed ID: 31341985
[TBL] [Abstract][Full Text] [Related]
14. SBRT in Localized Renal Carcinoma: A Review of the Literature.
DE LA Pinta C; Latorre RG; Fuentes R
Anticancer Res; 2022 Feb; 42(2):667-674. PubMed ID: 35093865
[TBL] [Abstract][Full Text] [Related]
15. Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.
Yamamoto T; Kadoya N; Takeda K; Matsushita H; Umezawa R; Sato K; Kubozono M; Ito K; Ishikawa Y; Kozumi M; Takahashi N; Katagiri Y; Onishi H; Jingu K
Radiat Oncol; 2016 May; 11():72. PubMed ID: 27229710
[TBL] [Abstract][Full Text] [Related]
16. Radiation Therapy in the Treatment of Localized and Advanced Renal Cancer.
Yim K; Leeman JE
Urol Clin North Am; 2023 May; 50(2):325-334. PubMed ID: 36948675
[TBL] [Abstract][Full Text] [Related]
17. Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma.
Grubb WR; Ponsky L; Lo SS; Kharouta M; Traughber B; Sandstrom K; MacLennan GT; Shankar E; Gupta S; Machtay M; Ellis RJ
Radiother Oncol; 2021 Feb; 155():138-143. PubMed ID: 33214131
[TBL] [Abstract][Full Text] [Related]
18. [The therapeutic potential of ablative radiotherapy for metastatic renal cell cancer: a tumour deemed radiation resistant].
Coucke P; Jánváry Z; Jansen N
Rev Med Liege; 2014; 69 Suppl 1():94-100. PubMed ID: 24822313
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.
Kothari G; Louie AV; Pryor D; Vela I; Lo SS; Teh BS; Siva S
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S17. PubMed ID: 28917255
[TBL] [Abstract][Full Text] [Related]
20. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
